➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Dow
Express Scripts
Merck
Medtronic

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

TECHNETIUM TC 99M GENERATOR Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Technetium Tc 99m Generator patents expire, and when can generic versions of Technetium Tc 99m Generator launch?

Technetium Tc 99m Generator is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in TECHNETIUM TC 99M GENERATOR is technetium tc-99m sodium pertechnetate generator. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m sodium pertechnetate generator profile page.

Summary for TECHNETIUM TC 99M GENERATOR
Drug patent expirations by year for TECHNETIUM TC 99M GENERATOR
Recent Clinical Trials for TECHNETIUM TC 99M GENERATOR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alexander McEwanPhase 3
Winnipeg Regional Health AuthorityPhase 3
University of ManitobaPhase 3

See all TECHNETIUM TC 99M GENERATOR clinical trials

US Patents and Regulatory Information for TECHNETIUM TC 99M GENERATOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare TECHNETIUM TC 99M GENERATOR technetium tc-99m sodium pertechnetate generator SOLUTION;INTRAVENOUS, ORAL 017693-002 Dec 13, 2013 DISCN Yes No   Start Trial   Start Trial   Start Trial
Ge Healthcare TECHNETIUM TC 99M GENERATOR technetium tc-99m sodium pertechnetate generator SOLUTION;INTRAVENOUS, ORAL 017693-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Merck
Colorcon
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.